biote Corp. (BTMD)

Medicinal Chemicals & Botanical Products

Latest Price

$2.22

TTM P/E

5.16

Normalized P/E

Div Yield

Book Value

P/B Ratio

Valuation metrics

Norm. op. income: $29M (median of 5yr)

Tax rate: 19%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$2.62

+16% upside

Base FCF: $30M (median of recent 4yr)

Growth: 5%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$7.48

+233% upside

EPS: $0.74

Target P/E: 5×

Formula: EPS × P/E

P/E Fair Value

$3.70

+64% upside

47.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
325 CAPITAL LLC	4.55M	$6.0M	14.84%	--	2026-03-31
Bandera Partners LLC	2.07M	$2.0M	6.74%	-218.3K	2026-03-31
BlackRock, Inc.	1.74M	$2.0M	5.68%	-29.7K	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	1.11M	$1.0M	3.63%	--	2026-03-31
STATE STREET CORP	647.0K	--	2.11%	+46.8K	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	615.7K	--	2.01%	-4.6K	2026-03-31
DIMENSIONAL FUND ADVISORS LP	543.5K	--	1.77%	-24.0K	2026-03-31
GLOBEFLEX CAPITAL L P	272.4K	--	0.89%	--	2026-03-31
NORTHERN TRUST CORP	269.1K	--	0.88%	+11.0K	2026-03-31
RENAISSANCE TECHNOLOGIES LLC	265.9K	--	0.87%	+62.3K	2026-03-31